Fda Panel Is First Key Test For Biden’s Covid-19 Booster Plan

WASHINGTON — The Biden administration’s embattled plan to dispense COVID-19 booster shots to most Americans faced its first major hurdle Friday as a government advisory panel met to decide whether to endorse extra doses of the Pfizer vaccine. Scientists inside and outside the government have been divided in recent days over the need for boosters and who should get them, and the World Health Organization has strongly objected to rich nations giving a third round of shots when poor countries don’t have enough vaccine for their first. The panel, made up of outside experts who advise the Food and Drug Administration, weighed a less than clear-cut case: While research suggests immunity levels in those who have been vaccinated wane over time and boosters can reverse that, the Pfizer vaccine is still highly protective against severe illness and death, even amid the spread of the highly contagious delta variant. The FDA experts were scheduled to vote on one basic question: Does the evidence show that a Pfizer booster would be safe and effective for people 16 and older?

Topics:  washington   scientists   world health organization   drug administration   the fda   centers   disease control   prevention   the cdc   separate fda   j&j   friday s   dr peter marks   fda s   jonathan sterne   israeli   sharon alroy-preis   israel s ministry    it s   related articles   one colorado    what s   black    experts   denver   coloradans   president joe biden s   sept   earlier   the biden   the u.s   some americans   in    the   biden    the biden   covid-19   health   fda   pfizer   cdc   u.s    americans     we   israel   july   colorado   covid   biden s   moderna   panel   test   booster plan   people   boosters   shots   data   months   government   dose   protection   top   doses   extra   delta   cases   older   levels   variant   week   countries   don   strongly   major   expected   plans   immunity   patients   highly   studies   advisory   systems   start   announced   effective   question   show   advisers   vote   shot   group   severe   adults   officials   
BING NEWS:
  • From KFF Health News
    Kids Can't Wait Any Longer For Social Media Safety When my son Conall took his life at age 17, it was devastating to me and our entire family. Conall was a caring, empathetic, and bright young man, ...
    04/17/2024 - 1:51 am | View Link
  • 10 doctors on FDA panel for Abbott heart device had financial ties to the company
    KFF Health News found records of Abbott payments associated with 10 of the 14 voting members of the FDA advisory panel, which was ... reviewing Pfizer’s covid-19 vaccine had been a Pfizer ...
    04/5/2024 - 11:00 pm | View Link
  • FDA authorizes new drug to protect immune compromised from Covid-19
    The Food and Drug Administration on Friday authorized a new antibody to protect immunocompromised individuals against Covid-19. The drug, known as Pemgarda and marketed by the biotech Invivyd ...
    03/21/2024 - 1:00 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Politics News